MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by KANG, S.
Right arrow Articles by OSMAN, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by KANG, S.
Right arrow Articles by OSMAN, R.

Molecular Pharmacology, Vol 16, 1031-1039, Copyright © 1979 by the American Society for Pharmacology and Experimental Therapeutics

[13C]NMR Chemical Shifts and Calculated Electronic Structures of Serotonin Congeners: Relation to Biological Activity

S. KANG 1, L. ERNST 2, H. WEINSTEIN 3, and R. OSMAN 3

1 Max Planck Institut, D-4600 Dortmund, Germany; and Department of Pharmacology, Mount Sinai School of Medicine, New York, N. Y. 10029
2 Gesellshaft fur Biotechnologische Forschung, D-5300 Braunschweig, Germany
3 Department of Pharmacology, Mount Sinai School of Medicine, New York, N.Y. 10029

[13C]NMR and quantum mechanical calculations of the electronic structure of some substituted tryptamines were applied to study the molecular determinants for the activity of these compounds on the LSD/serotonin receptor. A good correlation was observed between the measured [13C]chemical shifts and the gross atomic charges obtained from ab-initio and near ab-initio (pseudopotential) calculations. These parameters, however, did not correlate with the biological activity of the compounds measured by their potency in contracting the rat fundus or by their ability to displace D-LSD from a high-affinity binding site in brain homogenates from guinea pig. For example, 5-fluorotryptamine (5-FT) resembles tryptamine more than serotonin in its biological potency but is most similar to serotonin in both the measured [13C]chemical shifts and the calculated charge distribution. However, the frontier electron density maps above the indole portion of 5-FT bear a striking resemblance to those of tryptamine. The similar biological potency of 5-FT and tryptamine is in full accord with these findings and with results from our previous work from which the localization pattern of the electron density in the highest occupied molecular orbital emerged as a useful indicator of the relative affinity of tryptamines for the LSD/serotonin receptor. These conclusions support the use of judiciously chosen molecular reactivity criteria for the prediction of biological potency of drugs in this series.

Note:
ACKNOWLEDGMENTS The computations were supported in part by a grant of computer time from the University Computer Center of the City University of New York. Analysis of results in this work was carried out in part on the PROPHET System, a national computer resource sponsored by the NIH through the Chemical/Biological Information-Handling Program, Division of Research.

Submitted on January 8, 1979
Accepted on May 22, 1979







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1979 by the American Society for Pharmacology and Experimental Therapeutics